(S)-3-Amino-4-(4-bromophenyl)butanoic acid hydrochloride
98%
- Product Code: 81932
CAS:
331763-71-4
| Molecular Weight: | 294.573 g./mol | Molecular Formula: | C₁₀H₁₃BrClNO₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD01861014 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, inert gas protection |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various bioactive molecules, particularly those targeting neurological disorders. Its structure, featuring a bromophenyl group and an amino acid moiety, makes it valuable for developing drugs that interact with specific receptors or enzymes in the brain. Additionally, it is employed in the creation of peptide-based therapeutics, where its chiral center ensures the production of enantiomerically pure compounds. Researchers also explore its potential in designing inhibitors for enzymes involved in metabolic pathways, contributing to the development of novel treatments for diseases such as epilepsy or depression.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $237.32 |
+
-
|
| 0.250 | 10-20 days | $427.17 |
+
-
|
(S)-3-Amino-4-(4-bromophenyl)butanoic acid hydrochloride
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various bioactive molecules, particularly those targeting neurological disorders. Its structure, featuring a bromophenyl group and an amino acid moiety, makes it valuable for developing drugs that interact with specific receptors or enzymes in the brain. Additionally, it is employed in the creation of peptide-based therapeutics, where its chiral center ensures the production of enantiomerically pure compounds. Researchers also explore its potential in designing inhibitors for enzymes involved in metabolic pathways, contributing to the development of novel treatments for diseases such as epilepsy or depression.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :